| Sharon R Burnside, MD | |
|
6906 Kingston Pike, Suite 200, Knoxville, TN 37919-5704 | |
| (865) 588-4044 | |
| Not Available |
| Full Name | Sharon R Burnside |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 32 Years |
| Location | 6906 Kingston Pike, Knoxville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043231319 | NPI | - | NPPES |
| 1509819 | Medicaid | TN | |
| 3802260 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD028113 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Physicians Regional Medical Center | Powell, TN | Hospital |
| Entity Name | Sharon R. Burnside, M.d.,p.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972892081 PECOS PAC ID: 2567649056 Enrollment ID: O20110609000615 |
News Archive
British American Tobacco (BAT) has challenged the High Court against the cigarette plain packaging legislation. BAT argues the ban is invalid because the federal government is trying to acquire valuable intellectual property without compensation. BAT lodged the writs launching its challenge in the High Court Sydney registry on Thursday. The date for hearing is likely to be no earlier than the second quarter of next year.
WideMed, a leading company engaged in the research, development and sale of innovative products for the growing bio-medical signal diagnostics and treatment market, announced today that the U.S. Food and Drug Administration has granted its home sleep monitoring device, Morpheus Ox, clearance to market in the United States for cardiac patient population.
Adolor Corporation today announced that it has completed enrollment in its Phase 2 clinical evaluation of ADL5945 in chronic, non-cancer pain patients with opioid-induced constipation (OIC).
QLT Inc. ("QLT" or the "Company") today announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne(R) patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.
Individuals with kidney disease often suffer from cognitive impairment, but kidney transplantation can improve their mental performance, according to a paper being presented at the American Society of Nephrology's 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sharon R Burnside, MD Po Box 10687, Knoxville, TN 37939-0687 Ph: (865) 588-4044 | Sharon R Burnside, MD 6906 Kingston Pike, Suite 200, Knoxville, TN 37919-5704 Ph: (865) 588-4044 |
News Archive
British American Tobacco (BAT) has challenged the High Court against the cigarette plain packaging legislation. BAT argues the ban is invalid because the federal government is trying to acquire valuable intellectual property without compensation. BAT lodged the writs launching its challenge in the High Court Sydney registry on Thursday. The date for hearing is likely to be no earlier than the second quarter of next year.
WideMed, a leading company engaged in the research, development and sale of innovative products for the growing bio-medical signal diagnostics and treatment market, announced today that the U.S. Food and Drug Administration has granted its home sleep monitoring device, Morpheus Ox, clearance to market in the United States for cardiac patient population.
Adolor Corporation today announced that it has completed enrollment in its Phase 2 clinical evaluation of ADL5945 in chronic, non-cancer pain patients with opioid-induced constipation (OIC).
QLT Inc. ("QLT" or the "Company") today announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne(R) patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.
Individuals with kidney disease often suffer from cognitive impairment, but kidney transplantation can improve their mental performance, according to a paper being presented at the American Society of Nephrology's 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.
› Verified 6 days ago
Bertram R Henry, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 214 S Peters Rd, 101, Knoxville, TN 37923 Phone: 865-539-1001 Fax: 865-693-6393 | |
Dr. Namita Garg, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2018 W Clinch Avenue, Knoxville, TN 37916 Phone: 865-523-5437 Fax: 865-523-3559 | |
Michelle Lanter Brewer, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2200 Sutherland Ave., Knoxville, TN 37919 Phone: 865-521-6174 | |
Dr. Caryn Leslie Stoller, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1111 N Northshore Dr Ste S490, Knoxville, TN 37919 Phone: 865-584-0171 Fax: 865-584-0174 | |
Manju Khanna, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 600 Arthur St, Knoxville, TN 37921 Phone: 865-523-8695 | |
Dr. Raymond L Paine, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9401 Park West Blvd, Knoxville, TN 37923 Phone: 865-690-8190 Fax: 865-531-3536 |